ELI LILLY AND COMPANY Research and Development Expense
ELI LILLY AND COMPANY (LLY) reported Research and Development Expense of $2.36 billion for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2023-08-08
- ELI LILLY AND COMPANY research and development expense for the quarter ending 2023-06-30 was $2.36B, a 32.25% increase year-over-year.
- ELI LILLY AND COMPANY research and development expense for the quarter ending 2023-03-31 was $1.99B, a 23.29% increase year-over-year.
- ELI LILLY AND COMPANY research and development expense for the quarter ending 2022-12-31 was $2.00B, a 5.14% increase year-over-year.
- ELI LILLY AND COMPANY research and development expense for the quarter ending 2022-09-30 was $1.80B, a 5.72% increase year-over-year.
- ELI LILLY AND COMPANY research and development expense for fiscal 2022 was $7.19B, a 3.75% increase from fiscal 2021.
- ELI LILLY AND COMPANY research and development expense for fiscal 2021 was $6.93B, a 15.97% increase from fiscal 2020.
- ELI LILLY AND COMPANY research and development expense for fiscal 2020 was $5.98B, a 6.82% increase from fiscal 2019.
- ELI LILLY AND COMPANY research and development expense for fiscal 2019 was $5.59B, a 10.77% increase from fiscal 2018.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2023-06-30 | $2.36B 10-Q · filed 2023-08-08 | $4.34B 10-Q · filed 2023-08-08 | $6.34B derived: sum of 3 quarters · filed 2023-08-08 | $8.14B derived: sum of 4 quarters · filed 2023-08-08 | ||||
| 2023-03-31 | $1.99B 10-Q · filed 2023-04-27 | $3.98B derived: sum of 2 quarters · filed 2023-04-27 | $5.78B derived: sum of 3 quarters · filed 2023-04-27 | $7.57B derived: sum of 4 quarters · filed 2023-08-08 | ||||
| 2022-12-31 | $2.00B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $3.80B derived: sum of 2 quarters · filed 2023-02-22 | $5.58B derived: sum of 3 quarters · filed 2023-08-08 | $7.19B 10-K · filed 2023-02-22 | ||||
| 2022-09-30 | $1.80B 10-Q · filed 2022-11-01 | $3.58B derived: sum of 2 quarters · filed 2023-08-08 | $5.19B 10-Q · filed 2022-11-01 | $7.09B derived: sum of 4 quarters · filed 2023-08-08 | ||||
| 2022-06-30 | $1.78B 10-Q · filed 2023-08-08 | $3.39B 10-Q · filed 2023-08-08 | $5.29B derived: sum of 3 quarters · filed 2023-08-08 | $7.00B derived: sum of 4 quarters · filed 2023-08-08 | ||||
| 2022-03-31 | $1.61B 10-Q · filed 2023-04-27 | $3.51B derived: sum of 2 quarters · filed 2023-04-27 | $5.21B derived: sum of 3 quarters · filed 2023-04-27 | $6.87B derived: sum of 4 quarters · filed 2023-04-27 | ||||
| 2021-12-31 | $1.90B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $3.60B derived: sum of 2 quarters · filed 2023-02-22 | $5.26B derived: sum of 3 quarters · filed 2023-02-22 | $6.93B 10-K · filed 2023-02-22 | $7.03B 10-K · filed 2022-02-23 | |||
| 2021-09-30 | $1.71B 10-Q · filed 2022-11-01 | $1.71B 10-Q · filed 2021-10-27 | $3.36B derived: sum of 2 quarters · filed 2022-11-01 | $5.03B 10-Q · filed 2022-11-01 | $5.07B 10-Q · filed 2021-10-27 | $6.76B derived: sum of 4 quarters · filed 2023-02-22 | ||
| 2021-06-30 | $1.66B 10-Q · filed 2022-08-04 | $1.67B 10-Q · filed 2021-08-03 | $3.33B 10-Q · filed 2022-08-04 | $3.36B 10-Q · filed 2021-08-03 | $5.06B derived: sum of 3 quarters · filed 2023-02-22 | $6.52B derived: sum of 4 quarters · filed 2023-02-22 | ||
| 2021-03-31 | $1.67B 10-Q · filed 2022-04-29 | $1.68B 10-Q · filed 2021-04-30 | $3.40B derived: sum of 2 quarters · filed 2023-02-22 | $4.87B derived: sum of 3 quarters · filed 2023-02-22 | $6.26B derived: sum of 4 quarters · filed 2023-02-22 | |||
| 2020-12-31 | $1.73B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $3.19B derived: sum of 2 quarters · filed 2023-02-22 | $4.58B derived: sum of 3 quarters · filed 2023-02-22 | $5.98B 10-K · filed 2023-02-22 | $6.09B 10-K · filed 2021-02-17 | |||
| 2020-09-30 | $1.47B 10-Q · filed 2021-10-27 | $2.86B derived: sum of 2 quarters · filed 2021-10-27 | $4.25B 10-Q · filed 2021-10-27 | $5.83B derived: sum of 4 quarters · filed 2022-02-23 | ||||
| 2020-06-30 | $1.39B 10-Q · filed 2021-08-03 | $2.78B 10-Q · filed 2021-08-03 | $4.36B derived: sum of 3 quarters · filed 2022-02-23 | $5.74B derived: sum of 4 quarters · filed 2022-02-23 | ||||
| 2020-03-31 | $1.39B 10-Q · filed 2021-04-30 | $2.97B derived: sum of 2 quarters · filed 2022-02-23 | $4.35B derived: sum of 3 quarters · filed 2022-02-23 | $5.76B derived: sum of 4 quarters · filed 2022-02-23 | ||||
| 2019-12-31 | $1.58B derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $2.96B derived: sum of 2 quarters · filed 2022-02-23 | $4.36B derived: sum of 3 quarters · filed 2022-02-23 | $5.59B 10-K · filed 2022-02-23 | ||||
| 2019-09-30 | $1.38B 10-Q · filed 2020-10-28 | $2.78B derived: sum of 2 quarters · filed 2020-10-28 | $4.01B 10-Q · filed 2020-10-28 | $5.41B derived: sum of 4 quarters · filed 2021-02-17 | ||||
| 2019-06-30 | $1.40B 10-Q · filed 2020-07-31 | $2.63B 10-Q · filed 2020-07-31 | $4.02B derived: sum of 3 quarters · filed 2021-02-17 | $5.31B derived: sum of 4 quarters · filed 2021-02-17 | ||||
| 2019-03-31 | $1.23B 10-Q · filed 2020-05-01 | $2.62B derived: sum of 2 quarters · filed 2021-02-17 | $3.90B derived: sum of 3 quarters · filed 2021-02-17 | $5.17B derived: sum of 4 quarters · filed 2021-02-17 | ||||
| 2018-12-31 | $1.39B derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-17 | $2.67B derived: sum of 2 quarters · filed 2021-02-17 | $3.94B derived: sum of 3 quarters · filed 2021-02-17 | $5.05B 10-K · filed 2021-02-17 | $5.31B 10-K · filed 2019-02-19 | |||
| 2018-09-30 | $1.28B 10-Q · filed 2019-10-25 | $1.34B 10-Q · filed 2018-11-06 | $2.55B derived: sum of 2 quarters · filed 2019-10-25 | $3.66B 10-Q · filed 2019-10-25 | $3.85B 10-Q · filed 2018-11-06 | $4.89B derived: sum of 4 quarters · filed 2020-02-19 | ||
| 2018-06-30 | $1.27B 10-Q · filed 2019-08-02 | $1.33B 10-Q · filed 2018-07-25 | $2.38B 10-Q · filed 2019-08-02 | $2.51B 10-Q · filed 2018-07-25 | $3.60B derived: sum of 3 quarters · filed 2020-02-19 | $4.94B derived: sum of 4 quarters · filed 2020-02-19 | ||
| 2018-03-31 | $1.11B 10-Q · filed 2019-05-02 | $1.18B 10-Q · filed 2018-04-27 | $2.33B derived: sum of 2 quarters · filed 2020-02-19 | $3.67B derived: sum of 3 quarters · filed 2020-02-19 | $4.95B derived: sum of 4 quarters · filed 2020-02-19 | |||
| 2017-12-31 | $1.23B derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | $2.57B derived: sum of 2 quarters · filed 2020-02-19 | $3.84B derived: sum of 3 quarters · filed 2020-02-19 | $5.10B 10-K · filed 2020-02-19 | $5.28B 10-K · filed 2018-02-20 | |||
| 2017-09-30 | $1.34B 10-Q · filed 2018-11-06 | $1.32B 10-Q · filed 2017-10-27 | $2.61B derived: sum of 2 quarters · filed 2018-11-06 | $3.87B 10-Q · filed 2018-11-06 | $3.81B 10-Q · filed 2017-10-27 | $5.12B derived: sum of 4 quarters · filed 2019-10-24 | ||
| 2017-06-30 | $1.27B 10-Q · filed 2018-07-25 | $1.25B 10-Q · filed 2017-07-28 | $2.53B 10-Q · filed 2018-07-25 | $2.49B 10-Q · filed 2017-07-28 | $3.78B derived: sum of 3 quarters · filed 2019-10-24 | $5.01B derived: sum of 4 quarters · filed 2019-10-24 | ||
| 2017-03-31 | $1.26B 10-Q · filed 2018-04-27 | $1.24B 10-Q · filed 2017-05-01 | $2.50B derived: sum of 2 quarters · filed 2019-10-24 | $3.74B derived: sum of 3 quarters · filed 2019-10-24 | $5.08B derived: sum of 4 quarters · filed 2019-10-24 | |||
| 2016-12-31 | $1.25B derived: 8-K 12 month − 10-Q 9 month · filed 2019-10-24 | $2.48B derived: sum of 2 quarters · filed 2019-10-24 | $3.82B derived: sum of 3 quarters · filed 2019-10-24 | $5.04B 8-K · filed 2019-10-24 | $5.24B 10-K · filed 2017-02-21 | |||
| 2016-09-30 | $1.24B 10-Q · filed 2017-10-27 | $2.57B derived: sum of 2 quarters · filed 2017-10-27 | $3.79B 10-Q · filed 2017-10-27 | $5.24B derived: sum of 4 quarters · filed 2018-02-20 | ||||
| 2016-06-30 | $1.34B 10-Q · filed 2017-07-28 | $2.56B 10-Q · filed 2017-07-28 | $4.00B derived: sum of 3 quarters · filed 2018-02-20 | $5.14B derived: sum of 4 quarters · filed 2018-02-20 | ||||
| 2016-03-31 | $1.22B 10-Q · filed 2017-05-01 | $2.67B derived: sum of 2 quarters · filed 2018-02-20 | $3.81B derived: sum of 3 quarters · filed 2018-02-20 | $4.98B derived: sum of 4 quarters · filed 2018-02-20 | ||||
| 2015-12-31 | $1.44B derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-20 | $2.59B derived: sum of 2 quarters · filed 2018-02-20 | $3.76B derived: sum of 3 quarters · filed 2018-02-20 | $4.80B 10-K · filed 2018-02-20 | ||||
| 2015-09-30 | $1.14B 10-Q · filed 2016-10-28 | $2.31B derived: sum of 2 quarters · filed 2016-10-28 | $3.35B 10-Q · filed 2016-10-28 | $4.54B derived: sum of 4 quarters · filed 2017-02-21 | ||||
| 2015-06-30 | $1.17B 10-Q · filed 2016-07-28 | $2.21B 10-Q · filed 2016-07-28 | $3.39B derived: sum of 3 quarters · filed 2017-02-21 | $4.64B derived: sum of 4 quarters · filed 2017-02-21 | ||||
| 2015-03-31 | $1.04B 10-Q · filed 2016-04-29 | $2.23B derived: sum of 2 quarters · filed 2017-02-21 | $3.47B derived: sum of 3 quarters · filed 2017-02-21 | $4.66B derived: sum of 4 quarters · filed 2017-02-21 | ||||
| 2014-12-31 | $1.19B derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-21 | $2.43B derived: sum of 2 quarters · filed 2017-02-21 | $3.62B derived: sum of 3 quarters · filed 2017-02-21 | $4.73B 10-K · filed 2017-02-21 | ||||
| 2014-09-30 | $1.24B 10-Q · filed 2015-10-30 | $2.44B derived: sum of 2 quarters · filed 2015-10-30 | $3.55B 10-Q · filed 2015-10-30 | $5.02B derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2014-06-30 | $1.20B 10-Q · filed 2015-07-30 | $2.30B 10-Q · filed 2015-07-30 | $3.78B derived: sum of 3 quarters · filed 2016-02-19 | $5.16B derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2014-03-31 | $1.11B 10-Q · filed 2015-04-30 | $2.58B derived: sum of 2 quarters · filed 2016-02-19 | $3.96B derived: sum of 3 quarters · filed 2016-02-19 | $5.29B derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2013-12-31 | $1.48B derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | $2.85B derived: sum of 2 quarters · filed 2016-02-19 | $4.18B derived: sum of 3 quarters · filed 2016-02-19 | $5.53B 10-K · filed 2016-02-19 | ||||
| 2013-09-30 | $1.38B 10-Q · filed 2014-10-29 | $2.71B derived: sum of 2 quarters · filed 2014-10-29 | $4.06B 10-Q · filed 2014-10-29 | $5.52B derived: sum of 4 quarters · filed 2015-02-19 | ||||
| 2013-06-30 | $1.33B 10-Q · filed 2014-07-28 | $2.68B 10-Q · filed 2014-07-28 | $4.14B derived: sum of 3 quarters · filed 2015-02-19 | $5.48B derived: sum of 4 quarters · filed 2015-02-19 | ||||
| 2013-03-31 | $1.35B 10-Q · filed 2014-04-28 | $2.81B derived: sum of 2 quarters · filed 2015-02-19 | $4.15B derived: sum of 3 quarters · filed 2015-02-19 | $5.47B derived: sum of 4 quarters · filed 2015-02-19 | ||||
| 2012-12-31 | $1.46B derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-19 | $2.81B derived: sum of 2 quarters · filed 2015-02-19 | $4.13B derived: sum of 3 quarters · filed 2015-02-19 | $5.28B 10-K · filed 2015-02-19 | ||||
| 2012-09-30 | $1.34B 10-Q · filed 2013-10-30 | $2.66B derived: sum of 2 quarters · filed 2013-10-30 | $3.81B 10-Q · filed 2013-10-30 | $5.17B derived: sum of 4 quarters · filed 2014-02-19 | ||||
| 2012-06-30 | $1.32B 10-Q · filed 2013-07-26 | $2.47B 10-Q · filed 2013-07-26 | $3.83B derived: sum of 3 quarters · filed 2014-02-19 | $5.11B derived: sum of 4 quarters · filed 2014-02-19 | ||||
| 2012-03-31 | $1.15B 10-Q · filed 2013-04-26 | $2.51B derived: sum of 2 quarters · filed 2014-02-19 | $3.79B derived: sum of 3 quarters · filed 2014-02-19 | $5.05B derived: sum of 4 quarters · filed 2014-02-19 | ||||
| 2011-12-31 | $1.36B derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-19 | $2.64B derived: sum of 2 quarters · filed 2014-02-19 | $3.90B derived: sum of 3 quarters · filed 2014-02-19 | $5.02B 10-K · filed 2014-02-19 | ||||
| 2011-09-30 | $1.28B 10-Q · filed 2012-10-26 | $2.54B derived: sum of 2 quarters · filed 2012-10-26 | $3.67B 10-Q · filed 2012-10-26 | $5.10B derived: sum of 4 quarters · filed 2013-02-21 | ||||
| 2011-06-30 | $1.26B 10-Q · filed 2012-07-27 | $2.38B 10-Q · filed 2012-07-27 | $3.82B derived: sum of 3 quarters · filed 2013-02-21 | $5.04B derived: sum of 4 quarters · filed 2013-02-21 | ||||
| 2011-03-31 | $1.12B 10-Q · filed 2012-04-30 | $2.56B derived: sum of 2 quarters · filed 2013-02-21 | $3.78B derived: sum of 3 quarters · filed 2013-02-21 | $4.97B derived: sum of 4 quarters · filed 2013-02-21 | ||||
| 2010-12-31 | $1.44B derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21 | $2.66B derived: sum of 2 quarters · filed 2013-02-21 | $3.85B derived: sum of 3 quarters · filed 2013-02-21 | $4.88B 10-K · filed 2013-02-21 | ||||
| 2010-09-30 | $1.22B 10-Q · filed 2011-10-28 | $2.41B derived: sum of 2 quarters · filed 2011-10-28 | $3.45B 10-Q · filed 2011-10-28 | $4.66B derived: sum of 4 quarters · filed 2012-02-24 | ||||
| 2010-06-30 | $1.19B 10-Q · filed 2011-07-29 | $2.23B 10-Q · filed 2011-07-29 | $3.44B derived: sum of 3 quarters · filed 2012-02-24 | $4.57B derived: sum of 4 quarters · filed 2012-02-24 | ||||
| 2010-03-31 | $1.04B 10-Q · filed 2011-04-29 | $2.26B derived: sum of 2 quarters · filed 2012-02-24 | $3.38B derived: sum of 3 quarters · filed 2012-02-24 | $4.42B derived: sum of 4 quarters · filed 2012-02-24 | ||||
| 2009-12-31 | $1.22B derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-24 | $2.34B derived: sum of 2 quarters · filed 2012-02-24 | $3.38B derived: sum of 3 quarters · filed 2012-02-24 | $4.33B 10-K · filed 2012-02-24 | ||||
| 2009-09-30 | $1.12B 10-Q · filed 2010-10-29 | $2.16B derived: sum of 2 quarters · filed 2010-10-29 | $3.11B 10-Q · filed 2010-10-29 | $4.17B derived: sum of 4 quarters · filed 2011-02-22 | ||||
| 2009-06-30 | $1.04B 10-Q/A · filed 2010-08-02 | $1.99B 10-Q/A · filed 2010-08-02 | $3.05B derived: sum of 3 quarters · filed 2011-02-22 | $4.00B derived: sum of 4 quarters · filed 2011-02-22 | ||||
| 2009-03-31 | $947.30M 10-Q · filed 2010-07-30 | $2.01B derived: sum of 2 quarters · filed 2011-02-22 | $2.96B derived: sum of 3 quarters · filed 2011-02-22 | $3.91B derived: sum of 4 quarters · filed 2011-02-22 | ||||
| 2008-12-31 | $1.06B derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-22 | $2.01B derived: sum of 2 quarters · filed 2011-02-22 | $2.96B derived: sum of 3 quarters · filed 2011-02-22 | $3.84B 10-K · filed 2011-02-22 | ||||
| 2008-09-30 | $953.00M 10-Q · filed 2009-10-30 | $1.90B derived: sum of 2 quarters · filed 2009-10-30 | $2.78B 10-Q · filed 2009-10-30 | |||||
| 2008-06-30 | $951.50M 10-Q · filed 2009-07-31 | $1.83B 10-Q · filed 2009-07-31 | ||||||
| 2007-12-31 | $3.49B 10-K · filed 2010-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Akari Therapeutics Plc (AKTX) | $1,527.991B | -47,921.42 | |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |